CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Seegene’s novel real-time array technology is designed to accelerate the development of point-of-care testing by eliminating steps that normally follow PCR amplification, and that are required for conventional arrays. The new technology unifies all the steps into one.
There is no size limitation for the PCR amplicon, and the array technology requires no asymmetric PCR, denaturation of the PCR amplicon, target specific primer extension, signal amplification, or washing step.
The underlying chemistry of the technology adapts to automated systems, can be streamlined and standardized for molecular diagnostics, and is highly applicable to array-based point-of-care testing.
Seegene, 301-762-9066